Latest Regulatory Approvals News

Ore Resources has formalised a pivotal Project Agreement with the Marlinyu Ghoorlie people, setting the stage for mining lease approvals and advancing exploration at its Coolgardie Gold and Lithium Projects.

MAAS Group Holdings has delivered a record half-year underlying EBITDA of $115.3 million, driven by strong growth in construction and real estate segments. The company also announced a major $1.7 billion divestment of its Construction Materials portfolio and a strategic $100 million investment in digital infrastructure.

Sarytogan Graphite Limited has secured a crucial 27-year water licence for its Kazakhstan graphite project, marking a significant step in de-risking development. This approval complements prior permits and supports the upcoming feasibility study.

Singular Health Group reported a 55% rise in net loss to $2.97 million for H1 FY2026, driven by share-based payments and strategic hires, while making significant progress in US commercial deployments and securing FDA clearance for its cloud-based 3D medical imaging platform.

Vysarn Limited has reported a record first half for FY26 with revenue hitting $66.8 million and NPBT nearly doubling year-on-year to $10 million. The company reaffirms its full-year $20 million NPBT target, supported by strong industrial and advisory segment growth despite timing challenges in technology projects.

Havilah Resources has secured a $31.5 million cash payment and $15 million in exploration funding from Sandfire Resources, accelerating plans for drilling and development around the Kalkaroo copper-gold deposit in South Australia.

Atlantic Lithium has addressed recent share price volatility, linking it to shareholder speculation over the imminent ratification of its Ewoyaa Mining Lease in Ghana and rising lithium prices, while confirming the end of takeover discussions.

Hydrocarbon Dynamics Limited (HCD) is set to transform its business by acquiring the Great Bear Copper-Gold-Silver-Uranium Project in Canada, backed by a $5.5 million capital raise and plans to re-list on the ASX under a new name.

Lumos Diagnostics has hit a key enrollment milestone in its BARDA-funded paediatric study for FebriDx®, unlocking a US$720,000 payment and edging closer to FDA expansion.

Neurotech International has reported positive long-term safety results for its lead drug candidate NTI164, bolstering its path towards regulatory approval and chronic use in paediatric neurological disorders.

Toubani Resources has obtained the crucial environmental permit for its Kobada Gold Project, clearing the way for construction and initiating resettlement activities as planned.

Bindi Metals has secured regulatory approval to commence its maiden drilling program at the Ravni Gold Project in Serbia, while historic drill core resampling is underway with assay results expected soon.